DHJJ Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42K Sell
1,744
-23
-1% -$602 0.01% 441
2026
Q1
$49.6K Buy
1,767
+2
+0.1% +$53 0.02% 401
2025
Q4
$44K Buy
1,765
+2
+0.1% +$50 0.01% 405
2025
Q3
$44.9K Sell
1,763
-196
-10% -$4.84K 0.02% 377
2025
Q2
$47.5K Buy
1,959
+605
+45% +$14.1K 0.02% 352
2025
Q1
$34.3K Buy
1,354
+2
+0.1% +$52 0.01% 364
2024
Q4
$35.9K Buy
1,352
+2
+0.1% +$54 0.01% 354
2024
Q3
$39.1K Hold
1,350
0.02% 338
2024
Q2
$37.8K Hold
1,350
0.02% 314
2024
Q1
$37.5K Hold
1,350
0.02% 297
2023
Q4
$38.9K Buy
1,350
+6
+0.4% +$181 0.02% 288
2023
Q3
$44.6K Buy
+1,344
New +$47.5K 0.02% 255

Other funds holding PFE

DHJJ Financial Advisors's PFE Position: Q2 2026 in Review

DHJJ Financial Advisors reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $602 and leaving 1,744 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #441.

DHJJ Financial Advisors first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $49.6K in Q1 2026. 889 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • DHJJ Financial Advisors held 1,744 shares of Pfizer worth $42K as of Q2 2026.
  • DHJJ Financial Advisors sold 23 Pfizer shares in Q2 2026, an estimated $602.
  • Pfizer made up 0.01% of DHJJ Financial Advisors's portfolio in Q2 2026, its #441 holding.
  • DHJJ Financial Advisors first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • DHJJ Financial Advisors's Pfizer position peaked at $49.6K in Q1 2026.
  • 889 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.